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activity shown. From evidence so far available it is
not, however, possible to formulate the factors to
which the lowered potency of the glucuronides is
due.
SUMMARY
The isolation and purification of the monoglu-
curonides of stilboestrol, hexoestrol and dienoestrol,
and their chemical and oestrogenic properties, are
described.
We are indebted to the Council of the Middlesex Hospital
Medical School for the provision of laboratory facilities for
this work, to Dr A. C. Bottomley for help with the statistical
side of the bioassays and to Mrs D. Cullif9rd and Mr B. D.
Shepherd for technical assistance and to the Medical Re-
search Council for a grant.
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Hyaluronic acid has now been known for ten years
and in this period the literature about it has become
both extensive and inconsistentL A number of sub-
stances with varying properties has been isolated by
different methods from umbilical cord, skin, vitreous
humour, synovial fluid, tumours and haemolytic
streptococci. In spite of the differences in their pro-
perties, all are called hyaluronic acid if they give
more or less viscous solutions and if they are com-
posed for the most part of glucuronic acid and
acetylglucosamine. There is no clear evidence
whether several substances exist with somewhat
similar properties, or whether the observed varia-
tions are due to contamination with unrelated
material, or to partial destruction of originally
homogeneous hyaluronic acid during the isolation.
As a prelude to an investigation of the effect of
various agents on the enzymic decomposition of
hyaluronic acid we have tried to define the con-
ditions under which a product with more clearly
defined properties can be prepared. This was neces-
sary because crude preparations differed greatly
in the rates at which they lost viscosity with
testis hyaluronidase. Contamination of the pre-
paration by substances activating or inhibiting the
enzyme is the most obvious explanation of this
phenomenon.
The elementary composition of a hyaluronic acid
preparation is of little value as a criterion of purity.
The likely contaminants have carbon and hydrogen
contents similar to those expected for hyaluronic
acid. The nitrogen content is a good index of heavy
contamination with protein, but no great confidence
should be placed on a 'correct' nitrogen value, for
this is easily attained by the simultaneous presence
of comparable amounts of protein and a nitrogen-
free polysaccharide. There is substantial agreement
that hyaluronic acid contains neither phosphorus
nor sulphur but freedom from sulphur has not often
been achieved in making preparations of hyaluronic
acid.
Apart from proximate analysis, hyaluronic acid
can be examined for its constituents: glucosamine,
glucuronic acid and acetic acid; and the equivalent
weight can be determined by titration with alkali.
These measurements have not often been made on
the preparations used as substrate in studies on
hyaluronidase. Where they have been made con-
siderable variation is apparent, especially in the case
of determinations of the equivalent weight. This
value should be 379 for the free acid, on the assump-
tion that the molecule is so large that the ends may
beneglected, but Meyer, Smyth&Dawson (1939) and
Meyer & Chaffee (1940) have given a series of values
ranging from 400 to 640, and our own values are
within this range. It seems likely that the carboxyl
group in at least part of the glucuronic acid is not
free. The existence of this type of linkage robs the
equivalent weight of some of its value as acriterion
of purity.
* On leave of absence from Rothamsted Experimental
Station, Harpenden, Herts.
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Viscosity has been widely used as an index of
purity and ofthe extent to which degradation of the
hyaluronic acid has been avoided during the pre-
paration. This is legitimate if we assume that the
native acid, in all the various sites where it occurs,
has the same original viscosity, for many treatments
are known whiQh reduce the viscosity but none that
increase it.
In Table 1 published values for the viscosity of
preparations of hyaluronic acid are collected. It is
clear that there is no uniformity in these values, and
it is interesting to note that some of these pre--
parations have been described by their producers
as undegraded although the viscosity comes low in
the list. For comparispn the values for fractions
made by the methods tto be described in this paper
are included in the same table.
acid but that the curve steepens as the concen-
tration increases. These two factors have been dis-
regarded in compiling the last column in Table 1 so
that an approximate comparison of the various pre-
parations can be made. In each case a value for the
relative viscosity* at the standard concentration of
1 g./l. has been derived from the relation
relative viscosity - 11+
conc. at which viscosity was measured
This approximation tends to exaggerate the vis-
cosities of those products that were measured at the
higher concentrations, but no better method of
getting comparative figures seems to be available.
With most of these preparations the curverelating
relativeviscosityto concentrationhasnot been given,
Table- 1. Comparison of the viscosities of various hyaturonic acid preparations
CordI
Cords
Strep
Cords
Syno
Cords
Vitre
Vitre
Cords
Pleu
Vitre
Cordi
Cordi
Source Ionic environment
3 0 15m-NaCl
3 0-067M-Phosphate
buffer, pH 7
tococci 0 15m-NaCl
BOlM-Citrate-phos-
phate buffer, pH 7
vial fluid 0 067M-Phosphate
buffer, pH 7
0 66M-NaCl
ous humour 0-15m-NaCl
ous humour 0-067aM-Phosphate
buffer
Borate, chloride,
phosphate, acetate
mixture; 0-34Min
all, pH 7
ral exudate 0415M-NaCl, neutral
,ous humour 0 5M-NaCl
s 0-083m-NaCl,
0 083M-citrate
buffer, pH 4-5
s 0 05M-NaCl,
0-05M-phosphate
buffer, pH 7
Temp.
(0)
20
20
21
-30
Concen-
tration
(g./l.)
2-5
1.0
1-0
3-8
20 1.0
34 1.0
21 1.0
20 1.0
25 2*3
20 1-8
25 2*5
25 16.5
25 1.0
The viscosities given in Table 1 were measured at
different temperatures, at different concentrations,
and in different ionic envirornments; part of the
variation is due to these factors. At low salt concen-
trations the viscosity is high and it is greatly affected
by slight variation in the salt concentration, but in
the range in which most of the values fall the effect
of changes in salt concentration is small. It is well
known that the increment in the viscosity of a salt
solution due to the presence of hyaluronic acid is
not proportional to the concentration of hyaluronic
Relative
viscosity
49.3
4-3
Relative
viscosity
reduced
to 1 g./l.
4.3
4-3
Reference
Meyer, Smyth & Dawson (1939)
Blix & Snellman (1945)
3*8 3 8 Seastone (1939)
10.0 3'4 Hale (1944)
2-55 2B55 Blix & Snellman (1945)
2-0 2-0 McClean & Hale (1941)
1*9 1.9 Seastone (1939)
1*85 1-85 Blix & Snellman (1945)
2-0 1-4 Haas (1946)
1-54 1-3 Meyer & Chaffee (1940)
1-4 1-16 Madinaveitia & Quibell (1940)
2-6 11 Madinaveitia & Stacey (1944)
8'2 8-2 This paper
and Blix & Snellman (1945) have found that its
slope varies from preparation to preparation.
The technique of fractionation used in this work
was tried in order to test the basic idea that 'hyal-
* The terminology used in recent papers has not always
been consistent. Here relative viscosity means the ratio of
flow time of the test solution to the flow time of a solution
with the same salt concentration. Relative viscosity-I is
a measure of the increase in viscosity due to the hyaluronic
acid. It is sometimes called the specific viscosity, but we
prefer to call it the viscosity increment.
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uronic acid' is a name for a family of substances
differing slightly in architecture and greatly in
particle size. It would seem that the other workers
in the field have tried to remove as much protein as
possible and have then precipitated all the more or
less viscous material in one fraction in spite of its
apparent heterogeneity. In this work the appear-
ance of viscous material in several fractions has not
been looked on as a disadvantage; the fractions differ
in their properties so much that nothing would be
gained by mixing them. There is no satisfactory
method of separating a mixture of protein and
hyaluronic acid in one operation when the two are
present in similar amounts. Digestion with com-
mercial trypsin is not permissible if one intends to
use the hyaluronic acid for studies on hyaluronidase
because the protease preparations we have used
inactivate hyaluronidase; there can be no certainty
that separation of the inactivator from the hyal-
uronic acid has been complete. Several of the pre-
parations referred to in Table 1 were made by
removing the protein by shaking with chloroform
and amyl or butyl alcohol. This process is very
satisfactory for the removal of small amounts of
protein in the final stages of a preparation, but the
operations are tedious if used at the beginning. We
prefer to precipitate most of the protein along with
only a small part of the hyaluronic acid as a mucin
clot and then to isolate the main part of the hyal-
uronic acid by the methods to be described.
EXPERIMENTAL
Preparation of hyaluronic acid
Human umbilical cords have been used as starting material
in all our work. They are washed carefully and then pre-
served in acetone. After lying for 1-6 weeks in acetone they
are cut up into pieces not more than 1 cm. long and
extracted for a few more days with fresh acetone. The
acetone is then drained off as completely as possible and the
cords are extracted with successive lots of water, using
about four times the cords' wet weight of water for each
extraction and leaving each one for at least 2 hr. The first
two extracts contain little but acetone and may be thrown
away, but the later extracts bringout some hyaluronic acid
accompanied by much protein. These extracts therefore
give a mucin clot on acidification; they are combined and
extraction is continued until the amount of clot is small.
Five to eight extractions may be necessary. The combined
extracts are taken to pH 3 and the clot collected so that it
can be worked up for hyaluronic acid along with other
fractions grossly contaminated with protein.
The residue is passed through a power-driven meat
grinder withi in. holes in the plate. To reduce the viscosity
the ground material is suspended in 3 vol. of approx.
0 I m-NaCl, and after some hours it is poured into a cloth
and the fluid is expressed by hand. The extraction is
repeated twice, and the new NaCl solution is allowed each
time tolie in contact with the cord for at least 12 hr. If
this work is not carried out in a cold room the fluids should
be kept saturated with chloroform at all times. For each
litre of the combined extracts 20 ml. of approx. 5N-HC1
are added with thorough stirring. If the initial washing
of the cords was adequate there will be only a small pre-
cipitate; this is stirred gently and intermittently during
some hours, until it coalesces into a string which is then
removed and added to the mucin clot fraction.
Hyaluronic acid can be precipitated from this fluid in
several different ways. The conventional methods of pre-
cipitation with several volumes of ethanol or acetone are
inconvenient because of the bulk of the fluid involved.
100 g. dry weight of washed cords (about 40 cords) give 6 1.
of extract at this stage. Two alternative precipitation pro-
cedures are described.
(a) (NH4)2SO4 (300 g.) are added to each litre of the
clear acid fluid. Purified hyaluronic acid is not precipitated
by (NH4)2SO4, but the residual protein in the solution
precipitates and brings out some hyaluronic acid with it.
The precipitate that separates entangles air forced out of
the solution by the salt; this is convenient for it is easier to
allow the mixture to stand till all the solid has collected at
the top, then to siphon off the subnatant fluid and compact
the solid scum by centrifuging, than to de-aerate and
centrifuge down the precipitate. To each litre of fluid 50 ml.
of pyridine are added and the mixture is shaken vigorously
by hand; some of the pyridine remains undissolved in the
(NH4)2SO4 solution and a little solid separates at the inter-
face. The mixture is allowed to settle, the clear fluid is
siphoned off and the interfacial material is compacted by
centrifuging. This centrifuging should be done in a covered
tube so that the pyridine does not evaporate, because the
pellicle remains insoluble only if some pyridine phase is
present. The pellicle generally contains little hyaluronic
acid. A further 250 g. of (NH4)2SO4 are now added. This
forces more pyridine out of solution and it brings with it
hyaluronic acid which stays at the interface between the
two liquids. On centrifuging in closed vessels, it becomes
a compact coherent sheet that can be lifted out of the
centrifuge tube with a pair of forceps. Approximately equal
amounts of hyaluronic acid are present in the original
(NH4)2SO4 precipitate and in the second pyridine pellicle,
but the former may contain as much as 20% of protein
and the latter only 5 % judging from the nitrogen content.
In each case the protein can be removed by shaking with
chloroform and amyl alcohol according to the Sevag
technique.
(b) A comparable method for separating hyaluronic acid
from the acid cord extract involves precipitation with acid
ethanol in the presence of (NH4)2SO4. It offers no advan-
tages over the method already described and involves
handling larger volumes of fluid, but there may be other
sources of hyaluronic acid with which it might have
advantages. Ethanol (1-33 vol.) is added to the acid fluid;
a fine gelatinous precipitate separates and this is entangled
with air bubbles. The whole precipitate may be sufficiently
coherent to float up in 1 hr., thus enabling one to siphon
away most of the fluid. If it fails to do this, the air is
removed from the precipitate by exposure to vacuum for
a few minutes. The precipitate will now sink and can be
centrifuged down. This precipitate is suspended evenly in
water and reprecipitated by addition of 1-33 vol. of ethanol;
on dialysis it goes into solution slowly as the ethanol is
removed. Solid (NH4)2SO4 is added to the ethanolic super-
natant fluid with vigorous mechanical stirring. It dissolves
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slowly and about 200 g. are needed to saturate 11. On
standing, the system separates into two layers; the lower
contains much (NH4)2S04 and little ethanol and the upper.
little (NH4),S04 and much ethanol. As a rule a precipitate
which is relatively uncontaminated hyaluronic acid collects
on the interface. When separation has proceeded so far
that both liquid layers are clear, as much of each as possible
is siphoned off and the interfacial material collected by
packing it into a coherent felt by centrifuging. It packs
very tightly when centrifuged and should be diluted with
water before dialysis, for otherwise a rigid jelly will be
formed that dialyzes slowly. The proportion in which these
two fractions appear varies from preparation.to prepara-
tion; there is always an ethanol precipitate, but sometimes
little or no material separates on the addition of (NH4)2SO4.
Residual protein is removed from these fractions, as from
the pyridine fractions, bythe Sevagtechnique. For effective
removal of protein from these viscous solutions, the con-
centration must be kept low. Solutions of crude hyaluronic
acid containing less than 2 g./l. at pH 4 in the presence of
0)1-0- m-salt are shaken briskly by hand with a mixture
of one part chloroform to two of amyl alcohol, and then
centrifuged. The aqueous solution is shaken again, this
time mechanically, with fresh solvent. As a rule little or
no emulsion is made on this second shaking. After acidifi-
cation with HCI the fluid can be either dialyzed directly
or precipitated with 1-33 vol. of ethanol and then dialyzed
in a smaaller volume ofwater. In the latter case precipitation
will be incomplete, but this is an advantage because the
unprecipitated material has a lower viscosity than that
precipitated. It can be recovered as an interfacial pre-
cipitate by adding (NH4),S04.
The yield of purified material, by either of the two
methods, is 1-2% of the dry weight of the cords. The cord
residue and the mucin clots that have been precipitated by
adding acid to the extracts contain more hyaluronic acid,
and this can be iecovered, in a less viscous form, by
digestion with proteolytic enzymes. The cord residue, of
a consistency such that little more can be squeezed out of
it by hand, is suspended evenly in about 5 vol. of 0-01 .-HOl
containing 0.5 g./l. pepsin. The pH is readjusted to 2 if it is
significantly higher than this, and the mixture is incubated
with toluene for 24 hr. at 37°. The greater part dissolves
leaving a pink solution and a curd. These are easily
separated by filtration on a coarse paper at room tem-
perature. Sufficient gelatin is liberated into the fluid to
Pieces of umbilical cord after acetone extraction
Extracted with water
Residue
ground and extracted
with 0O 1m-NaCl
Resi ue Extract
digested with acidified
pepsin and
trypsin Mucin cli
Solution Fluid
acidified
Precipitate
(discarded)
Supernatant
ethanol
added
Precipitate: medium viscosity
hyaluronic acid
Fluid
Pyridine addedII.
Fluid
PrecipitateN(discarded) (NH4)2E
Fluid (discarded)
Procedure B
(NH4)2504
added
Precipitate (2)
804added
Extract
acidified
Mucin clot Fluid (discarded)
ot
Pooled mucin clot
digested with trypsin
Solution
acidified
Precipitate Supernatant
(discarded) ethanol added
Precipitate: low viscosity
hyaluronic acid
Procedure A
ethanol added
Fluid
(NH4)2SO4
added
Precipiitate (3)
Interfacial
precipitate (4)
Fluid
(discarded)
Interfacial precipitate (1)
Fig. 1. Processes used in the extraction of hyaluronic acid in different forms. Precipitates (1), (2), (3) and (4) are
shaken with chloroform and amyl alcohol to give hyaluronic acid fractions with variable but high viscosities.
---
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cause gelatinization if it is cooled. This pepsin extract gives
an ethanol precipitate and an interfacial precipitate in much
the same way as the extract from the minced cords, but
each has a high nitrogen content. It is preferable therefore
to neutralize the pepsin extract and digest it with trypsin to
destroy the 'protein that it contains. The cord residue is
also digested with trypsin and the two extracts are com-
bined. These digestions are carried out at 370 in the presence
of toluene with 2 g./l. commercial trypsin for 24 hr. at
pH 7-6. When these trypsin-digested fluids are put through
the acid-ethanol-(NH4)2S04 fractionation, nothing pre-
cipitates with the conc. HCI and very little interfacial
material separates. What there is, therefore, is added to the
ethanol precipitate and this precipitate is dissolved, repre-
cipitated, and dialyzed.
The mucin clot can be partially fractionated by pre-
cipitation with ethanolic potassium acetate in alkaline
solution as in McClean's (1943) method of purification, but
it is generally more satisfactory to incubate it with trypsin
and then work up the hyaluronic acid by ethanol pre-
cipitation in the manner just outlined for the pepsin extract
of the cord residue. The yields of these two products are
variable, but that from the pepsin extract may be as high
as 4%, and that from the mucin clots 1%, of the dry
weight of the cords. It is clear, therefore, that our methods
for the preparation of the viscous fractions of hyaluronic
acid lead to incomplete extraction in the first place and to
significant losses during the purification. This state of
affairs seems to be unavoidable if viscous preparations are
desired. Material from the pepsin extract has only half the
viscosity increment of the viscous fractions and that from
the mucin clots is even less viscous. Slightly more viscous
products can be made from these by precipitating a series
of fractions with ethanol or ethanolic potassium acetate,
but no product has been made from them at all resembling
the viscous fractions. In Fig. 1 an outline is given of the
processes used in making these various fractions, and also
of the sequence in which they occur.
Propertiem ofpreparations of hyaluronic acid
General
Umbilical cords that have been washed with
acetone and water and dried contain 2-5-3% of
amino sugar estimated as glucosamine by the
method of Elson & Morgan (1933). This amount
of glucosamine would correspond to 6-8% of hyal-
uronic acid, which is equal to the total yield that we
get. The non-viscous fractions however contain less
than the theoretical percentage of glucosamine.
Some of the glucosamine is therefore unaccounted
for, but it is clear that the greater part of the glucos-
amine of the cord is present in the form of poly-
saccharides that can be isolated by the methods
described here.
Preparations made from the acid-soluble part of
the original cord extract are all clear and colourless,
those made by digesting the mucin clot or the cord
residue are yellow or pink. The nitrogen content
(Kjeldahl) lies in the range 2-8-4 3 %. The phos-
phorus content is lower than 0 05 %, but sulphur
contents of 0.5-1 % are usual. The form in which
this sulphur occurs is not known. Viscous pre-
parations contain between 9 and 11 % of acetyl, but
preparations made by enzymic digestion of the
residues have lower acetyl contents, sometimes as
low as 6 %. The acetyl content was measured by
hydrolyzing a sample for 75 min. at 1000 in 2-5N-
H2SO4, steam distilling in the apparatus described
by Markham (1942) and titrating the distillate with
N/70 NaOH. There is a similar deficiency in the
glucosamine content; non-viscous preparations con-
tain 20-25 %, whereas viscous preparations contain
34-38 %. These values are in the range found by
most other workers. Glucosamine determinations
were made by the Elson & Morgan (1933) technique
on material that had been hydrolyzed for 6-8 hr. at
1000 with 5x-HCI and then evaporated to dryness in
a vacuum desiccator over NaOH. These analyses
were made on portions of dialyzed solutions, the
concentration ofwhich was determined by drying at
1000 for 1-2 hr., and cooling in a desiccator. They
refer to the free acid and not to a salt.
Viscosity
Viscosity measurements were made in Ostwald
viscosimeters with capillaries 9 cm. long and having
flow times of about 30 sec. for 4 ml. of water. This
volume was used in all the experiments reported
here and, except where another temperature is
specified, all measurements were made at 25°.
Viscosity measurements made in the absence of salt'
are of little significance; the large influence exerted
by low concentrations of salt makes such a measure-
ment an index of the completeness of dialysis rather
than of the state of aggregation of the hyaluronic
acid. From a consideration of the results ofMadina-
veitia & Quibell (1940) and of our own results we
have adopted 0-05M-NaCl and 0-05M-phosphate
buffer at pH 7-0 as the standard ionic environment
for measurements. Small variations in salt concen-
tration in this region have little effect on the
viscosity. Much of the work on hyaluronic acid has
been done at pH 7, and we adopted this pH because
we intended to use it ifs subsequent enzyme studies.
A more acid pH would be in some ways preferable,
for the viscosity of hyaluronic acid in 0-025M-citrate
buffer and 0-15M-NaCl, is unaffected by the pH in
the range 4-5-7-3. There is a sharp fall in viscosity
to about half the maximum between pH 4-5 and 2-6.
Above pH 7-3 there is a more gradual fall to 95%
of the maximum value at pH 8.5.
Pyridine precipitates, before the removal of re-
sidual protein by shaking with chloroform and amyl
alcohol, are the most viscous products that we have
encountered. Solutions containing 0-3 g./l. have a
relative viscosity in salt of 2-2-2-5, but this falls to
1-9-2-2 when the protein is removed. The results of
Blix & Snellman (1945) suggest that this may be due
to atmospheric oxidation during the shaking; it
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might be avoided, as they suggest, by shaking in
nitrogen but we have not tried this. The three other
viscous products, after removal of protein, have
relative viscosities of 1P7-2-0 for the0 3g./l. solution.
In these cases the removal of protein may be accom-
panied by either a rise or a fall in viscosity. Oc-
casional batches have had viscosities lower than this,
and there is a gradual fall in viscosity as solutions
age. Products from the cord residue have relative
viscosities of 1-3-1P5 at 0-3 g./l. and those from the
mucin clot 1-01-1-15. McClean & Hale (1941) and
Blix & Snellnan (1945) have published data on the
non-linearity of the relationship between viscosity
and the concentration of hyaluronic acid solutions.
Our results are in agreement; with viscous pre-
parations an increase in the concentration from 0-3
to 0-6 g./1. increases the viscosity increment three-
to fourfold, and solutions containing 1 g./l. have
a relative viscosity ofmore than 8. With less viscous
preparations the relationship is practically linear.
Effect8 of temperature on the vi8coaity
Differences in the temperature at which the
measurements were made must contribute to the
differences in the results collected in Table 1. The
flow times of 0-3 g./l. solutions of preparations
covering a range of viscosities have been%measured
at various temperatures in the salt mixture already
specified. The flow time of all is reduced by approxi-
mately one third between 20 and 37°, but much of
this reduction is due to the change in the viscosity of
the buffer solution. Over this temperature range the
change in viscosity increment is never more than
15% of the value at 200. Temperature is clearly not
a significant factor in explaining the differences
between products made in different laboratories.
Effect of different 8a1t8 on the vi8cotity
Madinaveitia & Quibell (1940) and McClean &
Hale (1941) have shown that the viscosity of
hyaluronic acid depends on the ionic environment.
We have tried the effect of several salts on different
preparations, and the results shown in Fig. 2 are
typical of those given by viscous preparations from
which the protein had been removed by the Sevag
technique. An abrupt fall in viscosity with traces
of salt is followed by a more gradual fall to a
minimum viscosity at about 0-5M. There is then
a gradual rise in relative viscosity; the values at 1 M
are approximately the same as those at 001 M.
x MgC126 CaC12
5
~ ~~~~ odu phosphate3Ma 5 eNso
NaCI
o KCI
: 4 NH4CI
2
1
0 0.J 0-2 0*3
Molarity of salt
Fig. 2. Change in the viscosity of hyaluronic acid solution
with varying concentrations of different salts. Temp. 250;
pH 7; 0 3 g./l. solution of a medium-viscous preparation.
Calcium and magnesium chlorides have clearly a
greater effect than the other salts, but no generaliza-
tions can be made on the basis of such a small
number of salts.
SUMMARY
1. Methods are described for preparing hyaluronic
acid from human umbilical cords.
2. By preparing a series offractions some products
have been made with a greater viscosity than any
hitherto described.
3. Some data on the chemical and physical pro-
perties of these fractions are given.
We wish to acknowledge with thanks the kind co-
operation of Dr Samuel Gwynne in obtaining the umbilical
cords. The investigation was aided by a grant from G. D.
Searle and Co.
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